Guardant Health Files Q3 2024 10-Q
Ticker: GH · Form: 10-Q · Filed: 2024-11-06T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, earnings, healthcare, financials
TL;DR
Guardant Health's Q3 2024 10-Q is in. Check financials for the latest.
AI Summary
Guardant Health, Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter of 2024 and provides financial updates. Key details include the company's fiscal year end of December 31 and its principal business address in Palo Alto, California.
Why It Matters
This filing provides investors with the latest financial performance and operational details for Guardant Health, crucial for understanding the company's trajectory in the diagnostics sector.
Risk Assessment
Risk Level: medium — As a publicly traded company in the healthcare sector, Guardant Health faces inherent market, regulatory, and competitive risks.
Key Numbers
- 2024 Q3 — Reporting Period (Covers the third quarter of 2024)
- 12-31 — Fiscal Year End (Indicates the end of the company's fiscal year)
Key Players & Entities
- Guardant Health, Inc. (company) — Filer of the 10-Q
- 2024-09-30 (date) — End of the reporting period
- 2024-11-06 (date) — Filing date
- Palo Alto, CA (location) — Company's business and mailing address
- Meghan Joyce (person) — Director
- Musa Tariq (person) — Director
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is September 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on November 6, 2024.
Where is Guardant Health, Inc. located?
Guardant Health, Inc.'s business and mailing address is 3100 Hanover Street, Palo Alto, CA 94304.
Who are listed as Directors in the filing header?
Meghan Joyce and Musa Tariq are listed as Directors.
What is Guardant Health's fiscal year end?
Guardant Health's fiscal year ends on December 31.
From the Filing
0001576280-24-000261.txt : 20241106 0001576280-24-000261.hdr.sgml : 20241106 20241106171245 ACCESSION NUMBER: 0001576280-24-000261 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 83 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241106 DATE AS OF CHANGE: 20241106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 241432183 BUSINESS ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 10-Q 1 gh-20240930.htm 10-Q gh-20240930 false 2024 Q3 0001576280 12-31 0.0071523 Meghan Joyce Director 293 Musa Tariq Director 383 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure gh:segment gh:trading_day gh:patent gh:tranche 0001576280 2024-01-01 2024-09-30 0001576280 2024-11-01 0001576280 2024-09-30 0001576280 2023-12-31 0001576280 2024-07-01 2024-09-30 0001576280 2023-07-01 2023-09-30 0001576280 2023-01-01 2023-09-30 0001576280 us-gaap:CommonStockMember 2024-06-30 0001576280 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001576280 us-gaap:RetainedEarningsMember 2024-06-30 0001576280 2024-06-30 0001576280 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001576280 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001576280 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001576280 us-gaap:CommonStockMember 2024-09-30 0001576280 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001576280 us-gaap:RetainedEarningsMember 2024-09-30 0001576280 us-gaap:CommonStockMember 2023-06-30 0001576280 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001576280 us-gaap:RetainedEarningsMember 2023-06-30 0001576280 2023-06-30 0001576280 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001576280 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001576280 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001576280 us-gaap:CommonStockMember 2023-09-30 0001576280 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001576280 us-gaap:RetainedEarningsMember 2023-09-30 0001576280 2023-09-30 0001576280 us-gaap:CommonStockMember 2023-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001576280 us-gaap:RetainedEarningsMember 2023-12-31 0001576280 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001576280 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-09-30 0001576280 us-gaap:RetainedEarningsMember 2024-01-01 2024-09-30 0001576280 us-gaap:CommonStockMember 2022-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001576280 us-gaap:RetainedEarningsMember 2022-12-31 0001576280 2022-12-31 0001576280 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001576280 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0001576280 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001576280 2022-01-01 2022-12-31 0001576280 2023-06-01 2023-06-30 0001576280 gh:CustomerAMembe